Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (9345)	6/8/1998 12:08:00 PM
From: ChinuSFO	Read Replies (1) \| Respond to of 23519

First off, the CEO by accepting what figures say, came across as very pragmatic. 2/3 of Vivus share has been eroded by Viagra. He accepted that and did not try to put a spin on it. If he did so he would be projecting the investing community are a bunch of idiots. After that, he went on to say that that this is the honeymoon period for Viagra, some MUSE people have crossed over to Viagra and that not only they will come back to MUSE when they discover that Viagra does not work for them as well as MUSE, but that they will lead a few others into the MUSE fold from Viagra. Also, though not in so many words, he also said that the Viagra publicity has raised the awareness level of the people with ED and the drugs available to them in the market. This increased level of awareness will in due course lead people to try out MUSE. All in all it was a very positive interview.